Your browser doesn't support javascript.
loading
Osimertinib in advanced EGFR-T790M mutation-positive non-small cell lung cancer patients treated within the Special Use Medication Program in Spain: OSIREX-Spanish Lung Cancer Group.
Provencio, Mariano; Terrasa, Josefa; Garrido, Pilar; Campelo, Rosario García; Aparisi, Francisco; Diz, Pilar; Aguiar, David; García-Giron, Carlos; Hidalgo, Julia; Aguado, Carlos; González, Jorge García; Esteban, Emilio; Gómez-Aldavarí, Lorenzo; Moran, Teresa; Juan, Oscar; Chara, Luís Enrique; Marti, Juan L; Castro, Rafael López; Ortega, Ana Laura; Moreno, Elia Martínez; Coves, Juan; Sánchez Peña, Ana M; Bosch-Barrera, Joaquim; Gastaldo, Amparo Sánchez; Núñez, Natalia Fernández; Del Barco, Edel; Cobo, Manuel; Isla, Dolores; Majem, Margarita; Navarro, Fátima; Calvo, Virginia.
Affiliation
  • Provencio M; Medical Oncology Department, Hospital Universitario Puerta de Hierro, Majadahonda, Madrid, Spain. mprovenciop@gmail.com.
  • Terrasa J; Health Research Institute, Hospital Universitario Puerta de Hierro, Majadahonda, Madrid, Spain. mprovenciop@gmail.com.
  • Garrido P; Universidad Autónoma de Madrid, Madrid, Spain. mprovenciop@gmail.com.
  • Campelo RG; Medical Oncology Department, Hospital Universitari Son Espases, Islas Balears, Palma de Mallorca, Spain.
  • Aparisi F; Medical Oncology Department, IRYCIS Hospital Universitario Ramón y Cajal, Madrid, Spain.
  • Diz P; Medical Oncology Department, Hospital Universitario A Coruña, A Coruña, Spain.
  • Aguiar D; Instituto de Investigación Biomédica A Coruña INIBIC, A Coruña, Spain.
  • García-Giron C; Medical Oncology Department Valencia, Hospital General Universitario de Valencia, Madrid, Spain.
  • Hidalgo J; Medical Oncology Department León, Complejo Asistencial Universitario de León, Madrid, Spain.
  • Aguado C; Medical Oncology Department, Hospital Universitario de Gran Canaria Dr. Negrín, Las Palmas de GC, Spain.
  • González JG; Medical Oncology Department, Hospital Universitario De Burgos, Burgos, Spain.
  • Esteban E; Medical Oncology Department, Hospital Lluís Alcanyis, Xátiva, Valencia, Spain.
  • Gómez-Aldavarí L; Medical Oncology Department, Hospital Clínico San Carlos, Madrid, Spain.
  • Moran T; Medical Oncology Department Santiago de Compostela, Hospital Clínico Universitario de Santiago, Madrid, Spain.
  • Juan O; Medical Oncology Department, Hospital Universitario Central de Asturias, Oviedo, Spain.
  • Chara LE; Medical Oncology Department, Complejo Hospitalario Universitario de Albacete, Albacete, Spain.
  • Marti JL; Institut Català d'Oncologia Badalona, Medical Oncology Department, Badalona, Barcelona, Spain.
  • Castro RL; Hospital Universitari Germans Trias i Pujol, Barcelona, Badalona, Spain.
  • Ortega AL; Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Moreno EM; Badalona Applied Research Group in Oncology, Barcelona, Spain.
  • Coves J; Fundació Germans Trias i Pujol, Barcelona, Spain.
  • Sánchez Peña AM; Medical Oncology Department, Hospital Universitari i Politècnic La Fe, Valencia, Spain.
  • Bosch-Barrera J; Medical Oncology Department, Hospital Universitario de Guadalajara, Guadalajara, Spain.
  • Gastaldo AS; Medical Oncology Department, Hospital General Universitario de Alicante, Alicante, Spain.
  • Núñez NF; Medical Oncology Department, Hospital Clínico Universitario de Valladolid, Valladolid, Spain.
  • Del Barco E; Medical Oncology Department, Complejo Hospitalario de Jaen, Jaen, Spain.
  • Cobo M; Medical Oncology Department, Hospital Virgen de la Salud, Toledo, Spain.
  • Isla D; Medical Oncology Department, Hospital Son Llàtzer, Palma de Mallorca, Spain.
  • Majem M; Medical Oncology Department, Hospital Universitario de Getafe, Getafe, Madrid, Spain.
  • Navarro F; Department of Oncology, Catalan Institute of Oncology. Dr. Josep Trueta University Hospital, Girona, Spain.
  • Calvo V; Medical Oncology Department, Hospital Universitario Virgen del Rocío, Sevilla, Spain.
BMC Cancer ; 21(1): 230, 2021 Mar 06.
Article in En | MEDLINE | ID: mdl-33676426
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Acrylamides / Carcinoma, Non-Small-Cell Lung / Protein Kinase Inhibitors / Aniline Compounds / Lung Neoplasms Type of study: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: BMC Cancer Journal subject: NEOPLASIAS Year: 2021 Document type: Article Affiliation country: Spain Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Acrylamides / Carcinoma, Non-Small-Cell Lung / Protein Kinase Inhibitors / Aniline Compounds / Lung Neoplasms Type of study: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: BMC Cancer Journal subject: NEOPLASIAS Year: 2021 Document type: Article Affiliation country: Spain Country of publication: United kingdom